T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease with the potential to slow, stop or reverse the course of the disease.

Pharmaceutical

T3D Therapeutics

T3D Therapeutics' headquarters in Durham, NC, United States

John Didsbury

Warren Strittmatter

Stan Chamberlain

Michael Weiner

John A. Golden

Roger Bullock

Martin Farlow

Marwan Sabbagh

Pierre Tariot

Charles Lineberry

Thomas G. Mendell

Roberta Brinton

Suzanne Craft

Barry Buzogany

Michael Heneka

David B. Keim

Description

People

Jobs